Wednesday, 28 December 2016

Metformin Plus Syrosingopine Effectively Combats Cancer Cells

Metformin Plus Syrosingopine Effectively Combats Cancer Cells

A combination of a diabetes medication and an antihypertensive drug effectively fights cancer cells, according to a team of researchers at the University of Basel. They also report that specific cancer cells respond to this combination of drugs. Metformin is the most widely prescribed drug for the treatment of type 2 diabetes. Besides its blood sugar lowering effect, it also displays anti-cancer properties. The usual therapeutic dose, however, is too low to effectively fight cancer. The research team led by Prof. Michael Hall, at the Biozentrum of the University of Basel, has now made an unexpected discovery. The antihypertensive drug

Continue reading...

No comments:

Post a Comment